Literature DB >> 32042639

Hypofractionation in prostate cancer radiotherapy: a step forward towards clinical routine.

Barbara Vischioni1, Rachele Petrucci1, Francesca Valvo1.   

Abstract

Entities:  

Year:  2019        PMID： 32042639      PMCID： PMC6989845          DOI： 10.21037/tau.2019.11.06

Source DB:  PubMed          Journal:  Transl Androl Urol        ISSN： 2223-4683


× No keyword cloud information.
  24 in total

1.  How should we define value in cancer care?

Authors:  Scott Ramsey; Adam Schickedanz
Journal:  Oncologist       Date:  2010

2.  Risk-based management of prostate cancer.

Authors:  Anthony V D'Amico
Journal:  N Engl J Med       Date:  2011-07-14       Impact factor: 91.245

3.  Rationale and protocol of AIRC IG-13218, short-term radiotherapy for early prostate cancer with concomitant boost to the dominant lesion.

Authors:  Giorgia Timon; Delia Ciardo; Alessia Bazani; Maria Garioni; Davide Maestri; Daniela De Lorenzo; Floriana Pansini; Raffaella Cambria; Elena Rondi; Federica Cattani; Giulia Marvaso; Dario Zerini; Barbara Vischioni; Mario Ciocca; Stefania Russo; Silvia Molinelli; Federica Golino; Valerio Scroffi; Damaris P Rojas; Cristiana Fodor; Giuseppe Petralia; Luigi Santoro; Ottavio De Cobelli; Roberto Orecchia; Barbara A Jereczek-Fossa
Journal:  Tumori       Date:  2016-08-05       Impact factor: 2.098

4.  Phase II multi-institutional clinical trial on a new mixed beam RT scheme of IMRT on pelvis combined with a carbon ion boost for high-risk prostate cancer patients.

Authors:  Giulia Marvaso; Barbara A Jereczek-Fossa; Barbara Vischioni; Delia Ciardo; Tommaso Giandini; Azusa Hasegawa; Federica Cattani; Mauro Carrara; Mario Ciocca; Nice Bedini; Sergio Villa; Sara Morlino; Stefania Russo; Dario Zerini; Sarah Pia Colangione; Costanza Maria Vittoria Panaino; Cristiana Fodor; Luigi Santoro; Emanuele Pignoli; Francesca Valvo; Riccardo Valdagni; Ottavio De Cobelli; Roberto Orecchia
Journal:  Tumori       Date:  2016-12-02       Impact factor: 2.098

5.  Carbon ion radiotherapy in advanced hypofractionated regimens for prostate cancer: from 20 to 16 fractions.

Authors:  Tohru Okada; Hiroshi Tsuji; Tadashi Kamada; Koichiro Akakura; Hiroyoshi Suzuki; Jun Shimazaki; Hirohiko Tsujii
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-08-14       Impact factor: 7.038

6.  Validation of an RNA cell cycle progression score for predicting death from prostate cancer in a conservatively managed needle biopsy cohort.

Authors:  J Cuzick; S Stone; G Fisher; Z H Yang; B V North; D M Berney; L Beltran; D Greenberg; H Møller; J E Reid; A Gutin; J S Lanchbury; M Brawer; P Scardino
Journal:  Br J Cancer       Date:  2015-06-23       Impact factor: 7.640

Review 7.  Contemporary approach to active surveillance for favorable risk prostate cancer.

Authors:  Laurence Klotz
Journal:  Asian J Urol       Date:  2018-12-15

Review 8.  Particle therapy for prostate cancer: The past, present and future.

Authors:  Hitoshi Ishikawa; Hiroshi Tsuji; Shigeyuki Murayama; Mikio Sugimoto; Nobuo Shinohara; Satoru Maruyama; Motohiro Murakami; Hiroki Shirato; Hideyuki Sakurai
Journal:  Int J Urol       Date:  2019-07-08       Impact factor: 3.369

9.  Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial.

Authors:  Anna Wilkins; Helen Mossop; Isabel Syndikus; Vincent Khoo; David Bloomfield; Chris Parker; John Logue; Christopher Scrase; Helen Patterson; Alison Birtle; John Staffurth; Zafar Malik; Miguel Panades; Chinnamani Eswar; John Graham; Martin Russell; Peter Kirkbride; Joe M O'Sullivan; Annie Gao; Clare Cruickshank; Clare Griffin; David Dearnaley; Emma Hall
Journal:  Lancet Oncol       Date:  2015-10-28       Impact factor: 41.316

10.  Initial toxicity, quality-of-life outcomes, and dosimetric impact in a randomized phase 3 trial of hypofractionated versus standard fractionated proton therapy for low-risk prostate cancer.

Authors:  Carlos E Vargas; Matthew Q Schmidt; Joshua R Niska; William F Hartsell; Sameer R Keole; Lucius Doh; John Han-Chih Chang; Christopher Sinesi; Rossio Rodriquez; Mark Pankuch; Gary L Larson
Journal:  Adv Radiat Oncol       Date:  2018-02-23
View more
  3 in total

1.  Potential role of functional imaging in predicting outcome for patients treated with carbon ion therapy: a review.

Authors:  Giulia Riva; Sara Imparato; Giovanni Savietto; Mattia Pecorilla; Alberto Iannalfi; Amelia Barcellini; Sara Ronchi; Maria Rosaria Fiore; Chiara Paganelli; Giulia Buizza; Mario Ciocca; Guido Baroni; Lorenzo Preda; Ester Orlandi
Journal:  Br J Radiol       Date:  2021-09-14       Impact factor: 3.039

Review 2.  History of Technological Advancements towards MR-Linac: The Future of Image-Guided Radiotherapy.

Authors:  Nikhil Rammohan; James W Randall; Poonam Yadav
Journal:  J Clin Med       Date:  2022-08-12       Impact factor: 4.964

3.  Abscopal effects of thoracic X-ray radiation on spermatogenesis in mice.

Authors:  Pan-Pan Lai; Yun-Tao Jing; Ling Guo; Tong-Zhou Qin; Yi-Zhe Xue; Zhao-Wen Zhang; Xing Wang; Xia Miao; Wei Zhang; Gui-Rong Ding
Journal:  Front Physiol       Date:  2022-08-26       Impact factor: 4.755
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.